A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

1992, Lancet, 339, 71, 10.1016/0140-6736(92)90997-H

10.1016/S0140-6736(97)11423-4

10.1056/NEJM200101253440407

10.1056/NEJM198902233200802

10.1093/jnci/88.21.1529

10.1093/jnci/93.9.684

Clinical announcement: adjuvant therapy of breast cancer — tamoxifen update. Bethesda, Md.: National Cancer Institute, November 1995.

10.1016/0022-4731(84)90197-3

Gottardis MM, 1988, Cancer Res, 48, 5183

10.1016/0960-0760(93)90060-A

10.1126/science.285.5428.744

10.1210/mend-5-11-1571

10.1016/0960-0760(96)00078-7

10.1016/S0959-8049(97)00100-7

10.1093/jnci/83.20.1477

10.1038/nrc721

10.1210/jc.80.10.2918

Goss PE, 2001, J Clin Oncol, 19, 881, 10.1200/JCO.2001.19.3.881

10.1023/A:1008368300827

10.1097/00005650-199206000-00002

Hilditch JR, 1996, Maturitas, 24, 161, 10.1016/0378-5122(96)01038-9

Tu D. Minimization procedure. In: Chow S-C, ed. Encyclopedia of biopharmaceutical statistics. 2nd ed., rev. New York: Marcel Dekker, 2003:614-8.

10.2307/2336502

Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer, 1997.

10.1097/00000421-200308001-00005

10.1016/S0140-6736(02)09088-8

10.1200/JCO.2002.06.020

10.1200/JCO.2003.04.596

10.1093/jnci/90.18.1371

10.1007/BF01811242

10.1056/NEJM199203263261302

10.1093/jnci/82.16.1327

Harper-Wynne C, 2002, Cancer Epidemiol Biomarkers Prev, 11, 614

10.1016/S0959-8049(01)00155-1

10.1359/jbmr.1998.13.5.763

Eastell R, 2002, Ann Oncol, 13, 32

Harper-Wynne C, 2001, Breast Cancer Res Treat, 69, 225

10.1016/0090-8258(74)90003-1

Henderson BE, 1989, Am J Obstet Gynecol, 161, 1859, 10.1016/S0002-9378(89)80007-9

10.1038/bjc.1990.356